Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Laudy, Agnieszka E ^a   Osińska, Paula ^a   Namysłowska, Alicja ^a   Zając, Olga ^a   Tyski, Stefan ^a,b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHYLAMINE; BETA LACTAM; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; NITROCEFIN; PHENYLALANYLARGININE BETA NAPHTHYLAMIDE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL OUTER MEMBRANE; BACTERIAL STRAIN; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MUTATION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CEPHALOSPORINS; GRAM-NEGATIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA;

EID: 84946170518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119997     Document Type: Article

References (33)

1. Pfeifer Y, Cullik A, WitteW(2010) Resistance to cephalosporins and carbapenems in gram-negative bacterial pathogens. Int J Med Microbiol 300: 371-379. doi: 10.1016/j.ijmm.2010.04.005 PMID: 20537585
2. Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18:657-686. PMID: 16223952
3. Kim YJ, Jun YH, Kim YR, Park KG, Park YJ, Kang JY, et al. (2014) Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis 14: 161. doi: 10.1186/1471-2334-14-161 PMID: 24655422
4. Cabot G, Ocampo-Sosa AA, Tabau F, Macia MD, Rodriguez C, Moya B, et al. (2011) Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a spainish multicenter study. Antimicrob Agents Chemother 55: 1906-1911. doi: 10.1128/AAC.01645-10 PMID: 21357294
5. Strateva T, Yordanov D (2009) Pseudomonas aeruginosa-a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148. doi: 10.1099/jmm.0.009142-0 PMID: 19528173
6. Rodriguez-Martinez JM, Poirel L, Nordmann P (2009) Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 4783-4788. doi: 10.1128/AAC.00574-09 PMID: 19738025
7. Vatcheva-Dobrevska R, Mulet X, Ivanov I, Zamorano L, Dobreva E, Velinov T, et al. (2013) Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals. Microb Drug Resist 19: 355-361. doi: 10.1089/mdr.2013.0004 PMID: 23600605
8. Qing Y, Cao KY, Fang ZL, Huang YM, Zhang XF, Yian GB, et al. (2014) Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates. J Med Microbiol 63: 386-392. doi: 10.1099/jmm.0.069427-0 PMID: 24398232
9. Viedma E, Juan C, Acosta J, Zamorano L, Otero JR, Sanz F, et al. (2009) Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extendedspectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother 53: 4930-4933. doi: 10.1128/AAC.00900-09 PMID: 19738007
10. Pitout JD, Laupland KB (2008) Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159-166. doi: 10.1016/S1473-3099(08)70041-0 PMID: 18291338
11. Kargar M, Kargar M, Jahromi MZ, Najafi A, Ghorbani-Dalini S (2014) Molecular detection of ESBLs production and antibiotic resistance patterns in Gram negative bacilli isolated from urinary tract infections. Indian J Pathol Microbiol 57: 244-248. doi: 10.4103/0377-4929.134688 PMID: 24943757
12. Picao RC, Poirel L, Gales AC, Nordmann P (2009) Further identyfication of CTX-M-2 extendedspectrum β-lactamase in Pseudomonas aeruginosa. Antimicrob Agents Chemother 53: 2225-2226. doi: 10.1128/AAC.01602-08 PMID: 19223647
13. Poole K (2011) Pseudomonas aeruginosa: resistance to the max. Frontiers in Microbiology 2 (article 65): 1-12.
14. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey J, et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406: 959-964. PMID: 10984043
15. Masuda N, Sakagawa E, Ohya S, Gotoh N, Tsujimoto H, Nishino T (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob Agents Chemother 44: 3322-3327. PMID: 11083635
16. Hocquet D, Nordmann P, Garch FE, Cabanne L, Plesiat P (2006) Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother 50: 1347-1351. PMID: 16569851
17. Bialek-Davenet S, Marcon E, Leflon-Guibout V, Lavigne JP, Bert F, Moreau R, et al. (2011) In vitro selection of ramR and soxR mutants overexpressing efflux systems by fluoroquinolones as well as cefoxitin in Klebsiella pneumoniae. Antimicrob Agents Chemother 55: 2795-2802. doi: 10.1128/AAC.00156-11 PMID: 21464248
18. Poole K (2012) Efflux-mediated antimicrobial resistance. In: Dougherty TJ, Pucci MJ, editors. Antibiotic discovery and development. Springer New York Dordrecht Heidelberg London. pp. 349-395.
19. Yasufuku T, Shigemura K, Shirakawa T, Matsumoto M, Nakano Y, Tanaka K, et al. (2011) Correlation of overexpression of efflux pump genes with antibiotic resistance in Escherichia coli strains clinically isolated from urinary tract infection patients. J Clin Microbiol 49: 189-194. doi: 10.1128/JCM.00827-10 PMID: 21048014
20. Alekshun M, Levy S (1997) Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 41: 2067-2075. PMID: 9333027
21. Srinivasan VB, Rajamohan G (2013) KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance. Antimicrob Agents Chemother 57: 4449-4462. doi: 10.1128/AAC.02284-12 PMID: 23836167
22. Lasocki K, Bartosik AA, Mierzejewska J, Thomas CM, Jagura-Burdzy G (2007) Deletion of the parA (soj) homologue in Pseudomonas aeruginosa causes ParB instability and affects growth rate, chromosome segregation, and motility. J Bacteriol 189: 5762-5772. PMID: 17545287
23. nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
24. 2+ and heat. BioTechniques 22: 54-56. PMID: 8994645
25. Drieux L, Brossier F, Sougakoff W, Jarlier V (2008) Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. Clin Microbiol Infect 14 (supl. 1): 90-103. PMID: 18154532
26. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second information supplement. Document M100-S22. Wayne, PA: CLSI; 2012.
27. Weldhagen GF, Poirel L, Nordmann P (2003) Ambler class A extender-spectrum β-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 47: 2385-2392. PMID: 12878494
28. th ed. Document M07-A9. Wayne, PA: CLSI; 2012
29. Matsumoto Y, Hayama K, Sakakihara S, Nishino K, Noji H, Iino R, et al. (2011) Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels. PLoS ONE 6: e18547. doi: 10. 1371/journal.pone.0018547 PMID: 21533264
30. Kong KF, Jayawardena SR, Indulkar SD, Puerto A, Koh CL, Høiby N, et al. (2005) Pseudomonas aeruginosa AmpR is a global transcriptional factor that regulates expression of AmpC and PoxB β-lactamases, proteases, quorum sensing, and other virulence factors. Antimicrob Agents Chemother 49: 4567-4575. PMID: 16251297
31. Lamers RP, Cavallari JF, Burrows LL (2013) The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAßN) permeabilizes the outer membrane of Gram-negative bacteria. PLoS ONE 8: e60666. doi: 10.1371/journal.pone.0060666 PMID: 23544160
32. Lomovskaya O, Warren MS, Lee A, Galazzo J, Fronko R, Lee M, et al. (2001) Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45: 105-116. PMID: 11120952
33. Renau TE, Leger R, Flamme EM, Sangalang J, She MW, Yen R, et al. (1999) Inhibitors of efflux pumps in Pseudomonas aeruginosa potential the activity of the fluoroquinolone antibacterial levofloxacin. J Med Chem 42: 4928-4931. PMID: 10585202